Get the content you want anytime you want.

Healthcare professionals and thought leaders share their knowledge and insights on an array of infectious disease topics

Latest Videos

<i>Pseudomonas aeruginosa</i>: Current & Future Treatment Options
Marin H. Kollef, MD, discusses treatment options for Pseudomonas aeruginosa.
<i>Clostridium difficile</i>: The Role of Bezlotoxumab
Lawrence J. Brandt, MD; Erik Dubberke, MD; Daniel E. Freedberg, MD, MS; Dale N. Gerding, MD; Yoav Golan, MD, MS; and Peter L. Salgo, MD, introduce bezlotoxumab, an additional treatment option that is in the pipeline for Clostridium difficile; explore how it works; and suggest which types of patients may be most appropriate to receive this treatment.
The Escalating Problem & Cost of Antimicrobial Resistance
Glenn Tillotson, PhD, FIDSA, provides insight into the growing problem and cost of antimicrobial resistance.
MDR Infections: Current Pathogen and Treatment Paradigm
Peter L. Salgo, MD; Andrew Shorr, MD; Jason Pogue, PharmD, BCPS-AQID; Sandy J. Estrada Lopez, PharmD, BCPS (AQID); and Debra Goff, PharmD, FCCP, identify the currently prevalent multidrug-resistant bacterial infections, which of these infections have benefited from the development of newer agents, and how treatment approaches may change with the advent of antibiotic stewardships.
Approach to Treating Lyme Disease Patients with Persistent Symptoms
Leonard Sigal, MD, explains his approach for treating Lyme disease patients with persistent symptoms.
Understanding the Causes and Impact of MDR Infections
Peter L. Salgo, MD; Jason Pogue, PharmD, BCPS-AQID; Andrew Shorr, MD; Sandy J. Estrada Lopez, PharmD, BCPS (AQID); and Debra Goff, PharmD, FCCP, speculate on the causes behind multidrug-resistant bacterial infections and identify how these infections are impacting patients of all populations.
What Are the Next Steps for Ridinilazole?
Dr. Richard Vickers, discusses what the next steps are for Summit Therapeutic’s ridinilazole.
What to Consider When Calling For Cultures
Marin H. Kollef, MD, discusses what to consider when calling for cultures.
The Centers of Disease Control and Prevention (CDC) held a recent briefing on flu season as 49 states report widespread flu activity.